Structure Therapeutics Inc.
GPCR· Nasdaq
Released May 8, 2025, after the close
10-Q filed May 8, 2025, 38 days after period end · 0001558370-25-006989
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$46.83M | -$26.04M | -$17.98M | -$13.08M |
| EPS Diluted | -$0.27 | -$0.19 | -$0.25 | -$1.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Structure Therapeutics Inc. · CIK 1888886 · Engraved from SEC EDGAR